First report of a blaNDM-5-carrying Escherichia coli sequence type 12 isolated from a dog with pyometra in Japan

• Published in: Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy Vol. 30; no. 9; pp. 938 - 941
• Main Authors: Harada, Kazuki, Miyamoto, Tadashi, Sugiyama, Michiyo, Asai, Tetsuo
• Format: Journal Article
• Language: English
• Published: Elsevier Ltd 01.09.2024
• Subjects: blaNDM-5; Carbapenemase-producing Enterobacterales; Dog; Escherichia coli; CRO; Carbapenemase-producing Enterobacterales; Escherichia coli; MBL; NDM; CPE; ESBL, extended-spectrum β-lactamaseIMP; NGS; blaNDM-5; Dog
• ISSN: 1341-321X; 1437-7780; 1437-7780
• DOI: 10.1016/j.jiac.2024.02.013

Carbapenemase-producing Enterobacterales (CPE) are a serious concern in human clinical settings. Companion animal–origin CPE have been only rarely identified in several countries, but they have not yet been identified in Japan. In this study, we present the first case of a canine infected with CPE in Japan. The patient was hospitalized due to pyometra. The pus discharged from the patient's uterus was subjected to bacteriological analysis. As a result, E. coli was identified in the pus and exhibited resistance to piperacillin, amoxicillin–clavulanic acid, cefazolin, ceftazidime, cefepime, meropenem, amikacin, and sulfamethoxazole–trimethoprim and susceptibility to aztreonam, minocycline, and levofloxacin. Results of the sodium mercaptoacetic acid double-disk synergy test showed that the E. coli isolate was positive for metallo-β-lactamases. Next-generation sequencing identified the blaNDM-5 gene, which was located in the IncFII-type plasmid together with blaTEM-1b, rmtB, aadA2, bleMBL, sul1, qacE, and dfrA12. The case was treated successfully with doxycycline and orbifloxacin. Our finding emphasizes that close attention should be paid to the significance of CPE harboring multidrug-resistance plasmid in companion animals, based on the perspective of One Health approach in Japan as well as in other countries.